BATF3 and metabolic syndrome: Although the treatment with 2-DG for 10 days may not be sufficient to reverse the metabolic syndrome in these mice, it demonstrates the central role of glucose metabolism in intestinal epithelial cells to the loss of barrier integrity and pro-inflammatory phenotype in the gut of Batf3-/- mice.